Sudapyridine not checked

Shanghai Jiatan Pharmatech Co., Ltd · WX-081

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
3 active
5 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Sudapyridine (WX-081) will be administered as a loading dose for 2 weeks (450 mg once daily for 7 days, followed by 300 mg once daily for 7 days) and a maintenance dose (150 mg once daily) from Week 3 to Week 24. The intervention is combined with background regimen (BR) and placebo for bedaquiline.”In the company’s words, NCT05824871 on ClinicalTrials.gov
Tested for
Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB), Rifampicin-Resistant Pulmonary Tuberculosis Patients, TB
Main trialPhase 3
“This is a multicenter, randomized, double-blind, active-controlled Phase III study to evaluate the efficacy and safety of Sudapyridine (WX-081) combined with a background regimen (BR) in patients with rifampicin-resistant pulmonary tuberculosis. Approximately 450 participants will be screened over a period of up to 2 weeks and randomized in a 2:1 ratio to receive either Sudapyridine or bedaquiline, in combination with placebo tablets and BR, for 24 weeks. After the treatment period, participants will enter a background regimen period up to Week 72, during which they will continue to receive…”In the company’s words, NCT05824871 on ClinicalTrials.gov
Other names
WX-081

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 22 Dec 2025 A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 1Not yet recruiting 12 Oct 2025 Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults
Phase 1Recruiting 12 Dec 2025 Pharmacokinetic Study of Sudapyridine(WX-081)in Healthy Chinese Subjects
Phase 2Completed 13 Apr 2022 Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081
Phase 1Completed 2 Jul 2020 Sudapyridine (WX-081) in Healthy Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Sudapyridine

Following is part of Solo: you see every change to Sudapyridine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in